BIOMAT Database Logo BIOMAT Database Logo

A clinical study of a new nonphenothiazine tranquilizer (SK&F--14336). 1969

O T Nikolovski, and R R Knowles, and B Korol

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000166 Acridines Compounds that include the structure of acridine. Acridine
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D014149 Tranquilizing Agents A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. Ataractics,Tranquilizing Drugs,Tranquilizing Effect,Tranquilizing Effects,Tranquillizing Agents,Tranquillizing Drugs,Agents, Tranquilizing,Agents, Tranquillizing,Drugs, Tranquilizing,Drugs, Tranquillizing,Effect, Tranquilizing,Effects, Tranquilizing

Related Publications

O T Nikolovski, and R R Knowles, and B Korol
A controlled study of SK&F 14336 in acute schizophrenia.
January 1967, The Journal of clinical pharmacology and the journal of new drugs,
O T Nikolovski, and R R Knowles, and B Korol
Clinical trial of SK&F 14336 concentrate for chronic psychotics.
January 1969, Current therapeutic research, clinical and experimental,
O T Nikolovski, and R R Knowles, and B Korol
Double blind study of an acridan derivative (SK & F 14336) versus chlorpromazine.
May 1968, Current therapeutic research, clinical and experimental,
O T Nikolovski, and R R Knowles, and B Korol
One-year trial of the antipsychotic acridan compound, SK&F 14336.
July 1969, Current therapeutic research, clinical and experimental,
O T Nikolovski, and R R Knowles, and B Korol
One-year trial of the antipsychotic acridan compound, SK AND F 14336.
June 1969, Behavioral neuropsychiatry,
O T Nikolovski, and R R Knowles, and B Korol
Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
January 1969, The Journal of clinical pharmacology and the journal of new drugs,
O T Nikolovski, and R R Knowles, and B Korol
Double-blind study comparing the intramuscular usage of an acridan derivative, SK&F 14336, to chlorpromazine.
January 1970, Current therapeutic research, clinical and experimental,
O T Nikolovski, and R R Knowles, and B Korol
[Clinical study of a new tranquilizer, Lexotan, in neurotic disorders].
April 1975, Semaine des hopitaux. Therapeutique,
O T Nikolovski, and R R Knowles, and B Korol
A clinical evaluation of a new psycholeptic acridan compound, SKF-14336.
September 1967, Current therapeutic research, clinical and experimental,
O T Nikolovski, and R R Knowles, and B Korol
Clinical trial of a new tranquilizer, prochlorperazine.
December 1957, The Medical annals of the District of Columbia,
Copied contents to your clipboard!